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The defense of cell volume against excessive shrinkage or swelling is a requirement for
cell function and organismal survival. Cell swelling triggers a coordinated homeostatic
response termed regulatory volume decrease (RVD), resulting in K+ and Cl− efflux
via activation of K+ channels, volume-regulated anion channels (VRACs), and the
K+-Cl− cotransporters, including KCC3. Here, we show genetic alanine (Ala) substitution
at threonines (Thr) 991 and 1048 in the KCC3a isoform carboxyl-terminus, preventing
inhibitory phosphorylation at these sites, not only significantly up-regulates KCC3a
activity up to 25-fold in normally inhibitory isotonic conditions, but is also accompanied
by reversal of activity of the related bumetanide-sensitive Na+-K+-2Cl− cotransporter
isoform 1 (NKCC1). This results in a rapid (<10min) and significant (>90%) reduction
in intracellular K+ content (Ki) via both Cl-dependent (KCC3a + NKCC1) and
Cl-independent [DCPIB (VRAC inhibitor)-sensitive] pathways, which collectively renders
cells less prone to acute swelling in hypotonic osmotic stress. Together, these data
demonstrate the phosphorylation state of Thr991/Thr1048 in KCC3a encodes a potent
switch of transporter activity, Ki homeostasis, and cell volume regulation, and reveal novel
observations into the functional interaction among ion transport molecules involved in
RVD.
Keywords: K-Cl cotransporters, KCC3, NKCC1, SPAK, cell volume homeostasis, regulatory volume decrease,
cerebral edema, neurodegeneration
Introduction
Regulation of cell volume is critical for multiple essential cellular functions and organismal survival.
Lacking a rigid cell wall, animal cells effectively combat excessive cell swelling or shrinkage, induced
by perturbations in intracellular ion content or extracellular osmolality, by triggering concerted
counter-responses termed regulatory volume decrease (RVD) or regulatory volume increase (RVI),
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respectively (Kregenow, 1971, 1981; Hoffmann and Dunham,
1995; Lauf and Adragna, 2000, 2012; Hoffmann et al., 2009).
These mechanisms are highly regulated by signaling molecules
that sense changes in intracellular ionic content and/or cell
volume, and transduce these signals to the cell membrane
to modulate the transport of ions and/or organic osmolytes
via the stimulation or inhibition of ion transporters, pumps,
and channels (Hoffmann and Dunham, 1995). The SLC12A
family of cation-Cl− cotransporters [including the Na+-
K+-2Cl− cotransporter isoform 1 NKCC1 and the K+-Cl−
cotransporters (KCCs), such as KCC3], the Na+/H+ exchangers
(e.g., NHE1), the Na+/K+ pump, and volume-regulated anion
channels (VRACs), are important plasmalemmal mediators of
ion transport in RVI and RVD (Hoffmann and Dunham, 1995;
Lauf and Adragna, 2000, 2012; Hoffmann et al., 2009).
K+-Cl− cotransport was first identified as a swelling- and
thiol-activated K+ efflux pathway in low-K+ sheep red blood
cells (Dunham et al., 1980; Lauf and Theg, 1980). The four KCC
isoforms (KCC1-4) utilize energetically favorable, outwardly-
directed K+ gradients to drive the extrusion of Cl− across
the plasma membrane. As such, they serve as important
determinants of both intracellular K+ and Cl− content, which
are important for cell volume regulation and other essential
functions depending on cell type (e.g., epithelial transport and
neuronal excitability) and KCC isoform (Lauf and Adragna,
2012). The physiological importance of the swelling-activated
KCCs, and in particular KCC3 (SLC12A6), is clearly illustrated
by the phenotypes that result from the knockout of the genes
encoding these molecules in mouse (Boettger et al., 2002; Delpire
andMount, 2002), and their mutations in humans (Howard et al.,
2002).
Loss-of-function mutations in human KCC3 cause the
autosomal recessive disease Andermann syndrome (OMIM #
218000), characterized by agenesis of the corpus callosum,
peripheral neuropathy (ACCPN), and seizures (Delpire and
Mount, 2002; Howard et al., 2002; Uyanik et al., 2006). KCC3 KO
mice recapitulate the human ACCPN phenotype (Howard et al.,
2002; Boettger et al., 2003) and studies in these mice have shown
that disease pathogenesis is associated with neuroglial swelling
and subsequent neurodegeneration resulting from impaired
RVD (Byun and Delpire, 2007). Dysfunction of the volume-
regulated KCCs has been implicated in other cell volume-related
pathologies (Adragna et al., 2004, 2006; Adragna and Lauf,
2007), such as RBC dehydration in sickle cell disease (Brugnara
et al., 1986; Brugnara, 1993, 1995, 2001; Joiner, 1993; Lew and
Bookchin, 2005) and inner ear cell degeneration in deafness
(Boettger et al., 2003).
Despite their physiological importance, the regulation of
the KCCs is not fully understood, though serine-threonine
kinases/phosphatases have long been known to play an essential
role (Jennings and Al-Rohil, 1990). Phosphorylation inhibits the
KCCs, while dephosphorylation has the opposite effect (Dunham
et al., 1980; Altamirano et al., 1988; Jennings and Schulz, 1991;
Lytle and Forbush, 1992; Haas and Forbush, 2000; Adragna
et al., 2004). KCC1, KCC3, and KCC4 are inactive in isotonic
conditions but briskly activated in response to hypotonic, low
Cl− cell-swelling conditions by a regulatory mechanism that
is evolutionarily-conserved (Haas and Forbush, 2000; Adragna
et al., 2004; Strange et al., 2006). KCC activation by hypotonic
cell swelling is prevented by calyculin A, an inhibitor of protein
phosphatase 1A (PP1) and PP2, further demonstrating the
importance of phosphorylation for KCC regulation (Lauf and
Adragna, 2000).
Two threonine (Thr) residues in human KCC3a,
Thr991, and Thr1048, were recently shown to undergo
rapid dephosphorylation in response to hypotonic low Cl−
(swelling/activating) conditions in HEK293 cells and human
RBCs (Rinehart et al., 2009; De Los Heros et al., 2014);
physiologically, these sites are phosphorylated in isotonic
(inhibitory) conditions. Homologous sites (i.e., “site 1” and
“site 2”) are phosphorylated in all human KCCs, including
KCC2, and double alanine substitution at these residues,
preventing phosphorylation, result in constitutively-active
KCC2 and KCC3 (Rinehart et al., 2009; De Los Heros et al.,
2014). The with no lysine [K] (WNK)-regulated STE20/SPS1-
related proline/alanine-rich kinase (SPAK) and oxidative stress
responsive kinase-1 (OSR1) kinases, known to regulate the
activity of the KCCs in oocytes (e.g., Kahle et al., 2005; Gagnon
et al., 2006), were recently shown to directly phosphorylate site
2 in the KCCs, but not site 1 (De Los Heros et al., 2014). The
kinase that directly phosphorylates site 1 in the KCCs has not yet
been identified (Rinehart et al., 2009).
Despite the detailed biochemical characterization of the
swelling-induced KCC3 Thr991/Thr1048 dephosphorylation
mechanism, the cellular physiology of this event has not been
systematically explored. Here, we utilized unidirectional net ion
flux uptake/loss assays under zero-trans conditions, to measure
intracellular K+ (Ki) content and uptake of
85Rb, and cell volume
analysis in two isogenic pairs of human epithelial cell lines
(HEK-293) engineered with doxycycline-inducible expression of
wild type KCC3 (KCC3 WT) or KCC3 Thr991Ala/Thr1048Ala
(i.e., “KCC3 AA,” preventing inhibitory phosphorylation), on (1)
KCC3 transport activity; (2) the activity of other key molecules
involved in cell volume homeostasis [e.g., NKCC1 and the
Na+/K+ pump (herein termed “NKP”)]; (3) Ki; and (4) cell
volume and RVD in conditions of hypotonic stress.
Materials and Methods
Chemicals
Chemicals from Thermo Fisher Scientific (Fair Lawn, NJ)
were: Tris (hydroxymethyl) aminomethane (Tris) free base,
3-morpholin-4-ylpropane-1-sulfonic acid (MOPS), sodium
chloride (NaCl), potassium chloride (KCl), magnesium
chloride (MgCl2), sodium hydroxide (NaOH), sucrose, D-
glucose, perchloric acid, 70% (PCA), and bicinchoninic acid
(BCA) protein assay reagents. Magnesium gluconate was
from Sigma-Aldrich (St. Louis, MO). 4-(2-hydroxyethyl)-
1-piperazine ethane sulfonic acid (HEPES) free acid, and
anhydrous calcium chloride (CaCl2), were from J.T.Baker
Chemical Co (Center Valley, PA). Rubidium chloride (RbCl),
99.8% (metals basis), and amidosulfonic acid (sulfamic acid,
S), 99.99% (metals basis) were purchased from Alfa Aesar
(Ward Hill, MA); N-methyl D-glucamine (NMDG) from
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Fluka Biochemika (St. Louis, MO); cesium chloride (CsCl) and
calcein-AM from Life technologies (Carlsbad, CA) and calcium
gluconate from Acros Organics (NJ). Ouabain octahydrate
was purchased from Calbiochem (San Diego, CA), furosemide
and bumetanide from Sigma-Aldrich (St. Louis, MO), 4-[(2-
Butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-
5-yl)oxy]butanoic acid (DCPIB), 1,2-Bis(2-aminophenoxy)
ethane-N,N,N′,N′-tetra acetic acid (BAPTA) from Tocris
Bioscience (Bristol, UK), tetra ethyl ammonium (TEA) from
Abcam (Cambridge, MA), clofilium tosylate from Enzo life
sciences (Farmingdale, NY), and 2,4-dichloro-N-isopropyl-N-
(2-isopropylaminoethyl)benzenesulfonamide (RN-1734) and
Ruthenium Red (RR) from Santa Cruz Biotechnology (Santa
Cruz, CA).
Solutions
The solution compositions for the different steps in the flux
protocol are as follows (with all salt concentrations in mM).
Initial wash: 300 mOsM balanced salt solution (BSS-NaCl) (20
HEPES-Tris, 5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 135 NaCl,
pH 7.4, 37 ◦C) or BSS-NaS (20 HEPES -Tris, 5 K+ sulfamate,
2 Ca gluconate, 1Mg gluconate, 10 glucose, 135 NaS, pH 7.4,
37 ◦C). Pre-incubation/equilibration: BSS-NaCl-BSA (bovine
serum albumin) (300 mOsM BSS-NaCl + 0.1 % BSA, pH 7.4,
37 ◦C) or BSS-NaS-BSA (300 mOsM BSS-NaS + 0.1 % BSA,
pH 7.4, 37 ◦C). Flux (in mM): 300 mOsM BSS-RbCl-BSA (20
HEPES -Tris, 10 RbCl, 2 CaCl2, 1 MgCl2, 10 glucose, 0.1 % BSA,
135 NaCl, pH 7.4, 37 ◦C) or BSS-RbS-BSA (20 HEPES -Tris, 10
Rb+ sulfamate, 2 Ca gluconate, 1Mg gluconate, 10 glucose, 0.1 %
BSA, 135 NaS, pH 7.4, 37 ◦C). Final wash: 300 mOsM containing
10 MOPS-TrisMgCl2, pH 7.4, 37
◦C (Supplementary Table 2).
Ions were extracted for 15min at 4 ◦Cwith 5 % perchloric acid
(PCA) andmeasured by atomic absorption spectrophotometry in
a Perkin Elmer 5000, as described elsewhere (Adragna et al., 2002;
Zhang et al., 2003). Total protein was determined by protein
extraction with 1M NaOH and measured with the BCA protein
assay as previously described (Di Fulvio et al., 2001).
Cell Line Construction and Culture
WT or AA (Thr991Ala/Thr1048Ala) human KCC3a cDNAs
harboring an N-terminal myc epitope (gifts of P. Gallagher,
Yale University), under the expression control of tetracycline,
were introduced as single copies into HEK-293 (Tet-On) cells
using the Flp-In™ T-REx™ System as described elsewhere
(Rinehart et al., 2009) (Supplementary Figure 2). Doxycycline, a
tetracycline derivative, was used to induce gene expression per
manufacturer’s directions (Life Technologies-Invitrogen, Grand
Island, NY 14072). Cells were cultured in Dulbecco’s Modified
Eagle Medium (DMEM) with high glucose (Life Technologies,
Catalog No. 11965-092), supplemented with 10 % tetracycline-
free fetal bovine serum (FBS) (Clontech, Catalog No. 631106),
100 units/mL penicillin, 100µg/mL streptomycin (Hyclone,
Catalog No. SV30010) and 10µg/mL blasticidin S hydrochloride
(Santa Cruz, Catalog No. sc-204655), and maintained in a
humidified incubator with 5 %CO2 at 37
◦C. For live cell imaging
experiments, viable cells (0.2×106 cells/well) were plated on poly-
D-Lysine coated glass coverslips (22×22mm) in 6-well plates. To
induce KCC3 (WT or AA) expression, cultures were treated with
1µg/mL doxycycline for up to 16 h.
Ion Flux Studies
Ion fluxes were measured according to previously published
protocols (Adragna et al., 2002; Zhang et al., 2003) with some
modifications. Cells were grown to 60 % confluence in 12-
well plates; KCC3 was expressed by overnight doxycycline (0–
1µg/ml) induction. 85Rb+ uptake or influx and intracellular
39K+ (Ki) content were determined under zero-trans conditions
as follows. WT- or AA-transfected cells were removed from
the incubator; culture medium was aspirated, washed three
times with 1ml 300 mOsM BSS-NaCl or BSS-NaS and then
equilibrated in BSS-NaCl-BSA or BSS-NaS-BSA for 10min.
Thereafter, supernatants were removed and then exposed to
pre-warmed flux media 300 mOsM BSS-RbCl-BSA or BSS-RbS-
BSA during pre-determined time points (0–15min). 85Rb+ was
used as a 39K+ congener (Lauf, 1983; Delpire and Lauf, 1991).
Thereafter, cells were washed with washing solution to block
Rb+ influx and K+ loss. Cellular Rb+ and K+ were extracted as
described above. Intracellular K+ was simultaneously measured
with a Na+-K+ lamp by absorption and Rb+ uptake with 85Rb+
by flame emission spectrophotometry in a Perkin-Elmer 5000
Atomic Absorption spectrophotometer (Perkin-Elmer, Boston
MA). Total protein was determined by the BCA assay as
described above. Rb+ uptake as a function of time and Ki,
(nanomoles per milligram protein) as a function of time were
calculated for each well as described elsewhere (Adragna, 1991).
Ouabain and bumetanide at final concentrations of 0.1mM and
10µM, respectively, were added to the flux media to block
the Na+/K+ pump (NKP) and Na+-K+-2Cl− cotransporter
(NKCC), respectively. NKP-mediated Rb+ influx was calculated
as the ouabain-sensitive flux (Cl - ClO) and NKCC as the
ouabain-insensitive but bumetanide-sensitive (ClO - ClOB) Rb+
influx in Cl− media, The Cl-dependent Rb+ influx (KCC) is
the calculated difference between the Rb+ influx in Cl− and S
media, both containing ouabain and bumetanide (ClOB - SOB)
(Supplementary Tables 1, 2).
Cell Volume Measurements
Cell volume change was determined using calcein as a marker
of intracellular water volume, as established previously (Lenart
et al., 2004). Briefly, cells on coverslips were incubated with
0.5µM calcein-AM for 30min at 37 ◦C. The cells were placed
in a heated (37 ◦C) imaging chamber (Warner Instruments,
Hamden, CT) on a Nikon Ti Eclipse inverted epifluorescence
microscope equipped with perfect focus, a 40X Super Fluor
oil immersion objective lens, and a Princeton Instruments
MicroMax CCD camera. Calcein fluorescence was monitored
using a FITC filter set (excitation 480 nm, emission 535 nm,
Chroma Technology, Rockingham, VT). Images were collected
every 60 s withMetaFluor image-acquisition software (Molecular
Devices, Sunnyvale, CA) and regions of interest (∼20–30 cells)
were selected. Baseline drift resulting from photo bleaching
and dye leakage was corrected as described previously (Lenart
et al., 2004). The fluorescence change was plotted as a function
of the reciprocal of the relative osmotic pressure and the
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resulting calibration curve applied to all subsequent experiments
as described previously (Lenart et al., 2004). The HEPES-
buffered isotonic solution contained (in mM) 100 NaCl, 5.4
KCl, 1.3 CaCl2, 0.8 MgSO4, 20 HEPES, 5.5 glucose, 0.4
NaHCO3, and 70 sucrose (pH 7.4) with 310 mOsM determined
using an osmometer (Advanced Instruments, Norwood, MA).
Anisosmotic solutions (150, 280, and 312 mOsM) were prepared
by removal or addition of sucrose to the above solution.
Statistical Analysis
The analysis of two samples in each or for independent
experiments was done by paired or unpaired t-test. Multiple
intergroup differences in each or for independent experiments
was conducted by One-Way analysis of variance (ANOVA) or
Kruskal–Wallis One-Way-ANOVA test followed by either, paired
or unpaired t-test, Wilcoxon signed-rank test, two-sample t-test
or Wilcoxon rank-sum test. A p < 0.05 was used as the criterion
of statistical significance. Except where indicated, all values were
obtained from three independent experiments in which at least
triplicate samples were assayed.
Results
An Isogenic Cell Line System with Inducible
Expression of Wild Type or
Constitutively-Dephosphorylated KCC3
(Thr991Ala/Thr1048Ala)
We constructed HEK-293 epithelial cell lines with doxycycline-
regulated expression of either N-terminal myc-tagged wild type
human KCC3a (“KCC3 WT”) or KCC3a Thr991A/Thr1048A
(“KCC3 AA”) inserted as a single copy, as described in Materials
and Methods. In the absence of doxycyline, KCC3 WT or AA
is not expressed (Supplementary Figure 1). However, in the
presence of doxycycline (0.1µM), anti-myc antibody revealed
robust expression of myc-tagged KCC3WT or KCC3 AA in 1.5 h
(Supplementary Figure 1). KCC3 expression and localization was
similar across multiple clonal cell lines of both KCC3 WT and
KCC3 AA (data not shown). Consistent with previous reports
(Rinehart et al., 2009; De Los Heros et al., 2014), KCC3 in
isotonic conditions was phosphorylated at both Thr991 and
Thr1048 (Supplementary Figure 1), as revealed using phospho-
specific antibodies raised against these residues (De Los Heros
et al., 2014). Hypotonic low Cl− conditions that stimulate KCC3
activity elicited dephosphorylation at Thr991 and Thr1048 in
KCC3 WT (data not shown), and mutation of these residues to
alanine (A) in KCC3 AA prevented phosphorylation at each site
(Supplementary Figure 1).
Constitutive KCC3 Thr991/Thr1048
Dephosphorylation Potently Stimulates KCC3
and is Associated with a Reversal of NKCC1
Activity in Flux Conditions
As a reminder 85Rb+ (a K+ congener) was used in uptake
assays and 39K+ under zero-trans conditions for Ki content
determinations to measure the activities of KCC, NKCC, and
NKP (see Materials and Methods for details).
It is also important to stress that only one technique is used
to determine simultaneously (in the same cells and at the same
time) both Rb+ influx and Ki content, which are measured by
atomic absorption (K+) and emission (Rb+) spectrophotometry.
Briefly, the technique consists of the following main steps: (1)
Cells plated on 12-well plates; (2) Culture medium removal from
wells at confluence; (3) Overnight incubation with doxycycline
(Induction); (4) Washing of cells 3×; (5) Equilibration with
solutions of similar composition as the flux solutions containing
K+ but not Rb+ (Preincubation); (6) Flux with solutions
containing Rb+ but not K+ (Flux); (7) Washing of cells 3 times;
(8) Further processing for cations and protein determinations
(See Materials and Methods for more details and Supplementary
Tables 1, 2).
This technique, which has been developed several decades ago,
allows to measure simultaneously unidirectional fluxes under 0-
trans conditions (Rb+ influx and K+ efflux) without the use
of radioisotopes (Lauf, 1983; Delpire and Lauf, 1991), and was
applied when measuring simultaneously K+ loss and Rb+ influx
through the IK channel of lens epithelial cells (Lauf et al., 2008).
This technique also allows measuring Ki in a simplified manner,
especially in KCC3 AA cells, because Ki loss is of such magnitude
that the signal to noise ratio is large enough to produce accurate
data.
Rb+ influx through KCC is defined as the difference in
Rb+ influx between Cl-containing and Cl-free medium with
sulfamate (S) as Cl− replacement, in the presence of both
ouabain (a NKP inhibitor) and bumetanide (a NKCC inhibitor);
Rb+ influx through NKCC is defined as the ouabain-insensitive
and bumetanide-sensitive Rb+ influx in Cl-containing media;
and Rb+ influx through NKP is defined as the ouabain-
sensitive Rb+ influx in Cl-containing medium (Supplementary
Tables 1, 2).
Induction of KCC3 WT in isotonic conditions did not elicit
a significant KCC-mediated Rb+ influx. For instance, in control
cells (i.e., cells not induced with doxycycline) the Rb+ influx
was 10.6 ± 1.8 nmol/mg protein × 5min, whereas in cells
induced with doxycycline (shown in Figure 1B), it was 12.4 ±
0.9 nmol/mg protein × 5min, n = 12 individual determinations
from 4 independent experiments, consistent with the presence
of inhibitory phosphorylation of KCC3 at Thr991 and Thr1048
(Supplementary Figure 1). Likewise, in KCC3 WT cells, NKCC
was 30.2 ± 7.4 in non-induced cells and 29.7 ± 6.0 nmol/mg
protein × 5min in induced cells (shown in Figure 1B),
n = 12 individual determinations from 4 independent
experiments.
In contrast, induction of KCC3 AA caused a significant
increase in Rb+ influx in Cl− and ouabain +/− bumetanide
media (ClO and ClOB), which was almost completely inhibited
in Cl-free medium (SOB) (Figure 1A), resulting in a greater
than ∼10-fold elevation of KCC activity [non-induced cells,
19.1 ± 0.42 nmol/mg protein × 5min and in induced cells
(shown in Figure 1B), 266.1± 2.2 nmol/mg protein× 5min, n =
12 individual determinations from 4 independent experiments,
p < 0.00001]. This effect was associated with a ∼5-fold decrease
in NKCC activity; note the negative NKCC value in Figure 1B
that was calculated as the difference between ClO - ClOB Rb+
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FIGURE 1 | Constitutive KCC3 Thr991/Thr1048 dephosphorylation
stimulates KCC3 activity and is accompanied by a reversal of NKCC1
activity. Rb+ influx assays in isogenic cell lines harboring
doxycycline-inducible expression of either KCC3 wild type (WT) or
non-phosphorylatable KCC3 Thr991A/Thr1048A (AA) were performed as
described in Methods. (A) Rb+ influx was assessed in the following media:
Cl− + 0.1mM ouabain (ClO, red), Cl− + (ouabain + 10µM bumetanide)
(ClOB, green), S + (ouabain + bumetanide) (SOB, blue) after induction of the
indicated proteins (see Methods for details). (B) Calculated Rb+ flux through
NKCC and KCC as the Cl-dependent, ouabain-insensitive,
bumetanide-sensitive Rb+ influx (ClO - ClOB), and Cl-dependent, ouabain
and bumetanide-insensitive Rb+ influx (ClOB - SOB), respectively. Calculation
of NKCC in AA cells after induction resulted in a negative value due to a
larger Rb+ influx in ClOB than in ClO, i.e., CLO – CLOB = -NKCC (see
Results and Discussion for further details). Flux time, 5min; n = 9 individual
determinations for WT cells and n = 4 individual determinations for AA cells.
Total number of independent experiments N = 4 for WT and N = 5 for AA
cells. Results were similar among different cell clones for both WT and
AA. *p < 0.005; #p < 0.0005; data represent the mean ± SEM values.
Two-sample t-test was employed to determine the statistical significance of
the differences between WT and AA, as indicated.
influx (plotted in Figure 1A) [non-induced, 108.5 ± 3.2 and in
induced (shown in Figure 1B),−40.1±8.5 nmoles/mg protein×
5min, n = 12 individual determinations from 4 independent
experiments, p < 0.0005].
Analysis of the ouabain-sensitive Rb+ uptake component
revealed induction of KCC3 AA triggered a ∼3–4 fold increase
in NKP activation in 5min (Figure 2B) when compared with
NKP activity upon induction of KCC3 WT (Figure 2A, KCC3
WT 23.2 ± 1.0 and KCC3 AA 87.7 ± 12.9 nmol/mg protein −
5min), consistent with the known 3–4 fold stimulation of NKP
flux to its Vmax by intracellular Na
+ and extracellular K+ site
saturation (reviewed in Lauf and Adragna, 2012). This became
further evident when extracellular Na+ replacement by NMDG
eliminated NKP activity (Figure 3). No changes were observed
in Ki content between non-induced and induced KCC3WT cells
under the same conditions for KCC3 AA cells (data not shown).
These data show that prevention of KCC3 Thr991/Thr1048
inhibitory phosphorylation results in constitutive KCC3a
activity that is accompanied by concurrent NKCC1 reversal
(i.e., outward Rb+ efflux through NKCC1) and NKP
stimulation.
FIGURE 2 | Effect of constitutive KCC3 Thr991/Thr1048
dephosphorylation on KCC3, NKCC1, and NKP activity as a function of
flux time. Rb+ influx assays in isogenic cell lines harboring inducible
expression of either KCC3 wild type (WT) (A) or KCC3 Thr991A/Thr1048A (AA)
(B) were performed as described in Methods. Rb+ uptake was determined in
the following media: total uptake, Cl− alone (Cl), Cl− + ouabain (ClO), Cl− +
ouabain + bumetanide (ClOB), S + ouabain + bumetanide (SOB). NKP,
NKCC, and KCC represent the Rb+ influx through the corresponding
transporters. Data for WT (A) were represented in the same scale as for AA (B)
cells to show the quantitative difference in Rb+ uptake between these two
types of cells. Shown are 2 independent experiments, n = 9 individual
determinations for WT cells and n = 4 individual determinations from a single
experiment for AA cells. Total number of independent experiments, N = 3 for
both WT and AA cells. Data represent the mean ± SEM values. See legend to
Figure 1 for further details.
KCC3 Thr991/Thr1408 Dephosphorylation
Triggers Significant Cl-Dependent and
Cl-Independent Ki Loss
Because intracellular ions and water are determinants of cell
volume, any inward ion flux study would be incomplete without
considering the fate of the intracellular counter-ion content, in
our case Ki. Furthermore, as opposed to the Rb
+ influx data
shown above, KCC-mediated transport actually results in K+
loss (efflux) and requires Cl−. Figure 4 shows Ki in KCC3 WT
(Figure 4A) and KCC3 AA (Figure 4B) cells measured after
exposure to Cl− or S media in conditions of NKP inhibition
by ouabain, and NKCC inhibition by ouabain + bumetanide, in
both non-induced and induced cells. Note that in KCC3WT cells,
there was a 30 % loss of Ki in Cl-free medium (601± 5.2 in ClOB
vs. 417± 10.7 in SOB, i.e., 31.5± 1.5% in non-induced and 609±
10.6 in ClOB and 423 ± 15.9, i.e., 30.6 ± 1.8 % in induced WT
cells, n = 9 individual determinations for all the conditions).
Because this Ki loss occurred in S but not in Cl
− media,
it could not have occurred via KCC3, and instead appeared to
involve an unidentified K+ conductive route, such as a selective
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FIGURE 3 | Rb+ influx via KCC3, NKCC1, and NKP in Na+ and
N-methyl-D-glucamine (MDG) medium. Rb+ influx through the Na+/K+
pump (NKP), NKCC and KCC (red, green, and blue bars, respectively) was
calculated as ouabain sensitive; Cl-dependent, bumetanide-sensitive; and
Cl-dependent, ouabain and bumetanide-insensitive Rb+ influx, respectively.
KCC3 AA but not KCC3 WT (results not shown) induction causes a potent
increase in flux through KCC3, which is accompanied by inhibition of NKCC
and stimulation of NKP. The effects of KCC3 AA induction on NKCC and NKP
are abolished when extracellular Na+ is replaced with NMDG. n = 6 individual
determinations from a single experiment, total number of experiments
N = 2. #p < 0.05; *p < 0.005, n = 12, data represent the mean ± SEM
values. Two-sample t-test was employed to determine the statistical
significance of the differences between Na+ and MDG, as indicated.
K+ channel, non-selective cation channel, or transporter.
Surprisingly, induction of KCC3 AA triggered a ∼75 % Ki loss
in Cl− media, 50 % of which was recovered by incubating the
cells in S medium (see Figure 4B, compare ClO in non-induced
and induced cells, and ClO with SOB in induced cells, labeled as
Cl-dependent K+ loss), indicating inhibition of a Cl-dependent
Ki loss mechanism presumably through NKCC and KCC3. This
Cl-dependent Ki loss through NKCC and KCC3 increased as
a function of time, further depleting the cells of K+ (data not
shown), and was inhibited by replacing extracellular Rb+ with
K+, and 2mM furosemide, an inhibitor of KCC activity (data
not shown). In contrast, the remaining 50 % Ki loss was Cl-
independent (see Figure 4B, compare SOB in non-induced and
induced cells).
The Cl-dependent and Cl-independent Ki loss triggered
by KCC3 AA in isotonic conditions has not been previously
reported. The Cl-dependent K+ loss that presumably occurs via
KCC3 (see above), was matched by a significant increase in
Cl-dependent Rb+ uptake (Figure 1).
To explore mechanisms contributing to the Cl-independent
Ki loss, we performed ion replacement studies and tested
inhibitors of several different candidate transport systems (see
Supplementary Table 3). KCC3 AA-induced Cl-independent Ki
loss was unaffected by the following: Changes in extracellular
Na+ (data not shown); TEA (2mM) and clofilium (100µM),
inhibitors of multiple K+ channels (Iwatsuki and Petersen, 1985;
Arena and Kass, 1988; Gough and El-Sherif, 1989); Ruthenium
Red (1µM), a non-selective inhibitor of Ca2+ conductance;
FIGURE 4 | Constitutive KCC3 Thr991/Thr1048 dephosphorylation
elicits rapid and potent Cl-dependent and Cl-independent Ki loss. Ki
after flux in 10mM RbCl with ouabain (ClO); ouabain + bumetanide (ClOB);
and in 10mM RbS with ouabain + bumetanide (SOB) in the indicated cell lines
[A (WT), B (AA)] before and after induction with doxycyline. Induction of KCC3
AA results in a large decrease in Ki via K
+ efflux through KCC3. Use of the
Cl-free medium SOB partially reduces the magnitude of this Ki decrease,
indicating that there are both Cl-dependent and Cl-independent components
of the Ki decrease stimulated by KCC3 AA induction. Cl-dependent K
+ loss in
induced cells was calculated as the Ki content in SOB—that in ClO, whereas
the Cl-independent K+ loss was calculated as the difference in Ki content in
SOB between non-induced and induced cells. Flux time, 5min; n = 9
individual determinations from a single experiment for WT and n = 4 for AA
cells. Total number of independent experiments N = 4 for WT and N = 2 for
AA cells. There was a statistically significant difference between groups as
determined by Kruskal–Wallis One-Way ANOVA for Non-induced vs. Induced
(ClO, ClOB, and SOB) for WT [F(5, 48) = 21.55] and AA [F(5, 18) = 36.97],
p < 0.0005, n = 54 and 24, respectively. These differences were confirmed by
paired t-test for (ClOB vs. SOB) in Non-induced and Induced WT, *p < 0.0005,
and AA, +p < 0.05 (Non-induced) and *p < 0.0005 (Induced); whereas the
comparison between Non-induced vs. Induced AA was *p < 0.0005 for ClO
and ClOB, and #p < 0.005 for SOB. Data represent the mean ± SEM values.
BAPTA (100µM), an intracellular Ca2+ chelator (Tsien, 1980;
Tymianski et al., 1994); EDTA (1mM), an extracellular
Mg2+/Ca2+ chelator; and RN-1734 (30µM), a TRPV4 channel
blocker (Vincent et al., 2009; Vincent and Aj Duncton, 2011)
(data not shown and summarized in Supplementary Table 3).
Cl-Independent Ki Loss Elicited by KCC3
Thr991/Thr1048 Dephosphorylation is Sensitive
to the VRAC Inhibitor DCPIB
Unexpectedly, DCPIB, a blocker of volume-regulated Cl−
channel activity (VRAC, or ICl−swell), and known to inhibit K
+
loss through intermediate K+ (IK; KCa3.1) conductance channels
(Lauf et al., 2008) caused partial inhibition of K+ loss during
induction (Figure 5). Furthermore, DCPIB inhibited KCC3 AA-
induced Cl-independent Ki loss (Figure 6) while inhibiting
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FIGURE 5 | Constitutive KCC3 dephosphorylation elicits rapid and
potent cellular Ki loss, which is time-dependent and partially sensitive
to DCPIB. Ki content was measured as described in Materials and Methods
during induction with doxycycline (1.0µg/ml) and in the presence and absence
of DCPIB (50µM), an inhibitor of volume regulated Cl− channels (VRACs) and
intermediate K+ channels. Black squares, Control, i.e., no doxycycline or
DCPIB; red circles, doxycycline alone, and green triangles, doxycycline +
DCPIB. Time points where there was a significant change were compared vs.
the Control. n = 8 individual determinations. Total number of independent
identical experiments N = 2. *p < 0.001; data represent the mean ± SEM
values.
KCC and NKP and activating NKCC (Figure 7). DCPIB, dose-
dependently, also increased NKCC and Ki content but inhibited
KCC as a function of time when present during the flux
(Figure 8).
To further assess the effect of the VRAC inhibitor on the
main transporters studied, DCPIB (50µM) was applied during
the 3 main steps of the Rb+ influx protocol; i.e., during KCC3
AA induction (I), pre-incubation (P), flux (F), and in different
combinations (IP, IF, and IPF) (Figure 9, Supplementary Tables
1, 2). Three main components for K+ loss were defined and
were calculated as total KCC3 AA-induced K+ loss (T), Cl−
cotransporter-dependent K+ loss (ClCOT, i.e., through NKCC+
KCC, see Figure 10), and K+ channel-dependent K+ loss (KCH).
Figure 9 depicts the total KCC3 AA-induced K+ loss (T) through
its two components (ClCOT and KCH) in the various conditions.
Strikingly, statistically significant inhibition of KCH by
DCPIB was observed when the inhibitor was present during
induction (I) alone (I + DC in I) (p < 0.05), and complete
inhibition when it was present during I + flux (I + DC in IF)
(p < 0.005), n = 4 with respect to I alone, although there
was not statistically significant difference between groups (See
Figure 9 legend for more details). In the latter condition, Ki was
maintained at the control level. Similar results were observed
when the inhibitor was present during either induction +
preincubation (IP), or during induction + preincubation +
flux (IPF). These data show KCC3 AA-induced Cl-independent
Ki loss is DCPIB-sensitive, suggesting dependence on VRAC
activity.
The activities of the Cl-coupled cotransporters (NKCC and
KCC) were determined by measuring Rb+ influx or K+ loss
under identical conditions as in Figure 9 and the total Rb+
influx or K+ loss through NKCC + KCC are represented in
Figure 10 as their sum for Rb+ influx and for K loss. Note
that the sum of the two cotransporters was roughly constant for
FIGURE 6 | Constitutive KCC3 Thr991/Thr1048 dephosphorylation
elicits rapid and potent cellular Ki loss which is time-dependent and
partially sensitive to DCPIB. Ki content was measured as described in
Materials and Methods during induction with doxycycline (1µg/ml) and in the
presence and absence of DCPIB (50µM). (A) Ki content in Cl-free medium,
sulfamate (S) replacement without (SOB, black squares) and with DCPIB
(SOBD, red circles). (B) Ki content in Cl-media ± ouabain (0.1mM) ±
bumetanide (10µM) without (Cl, ClO and ClOB, black squares, red circles, and
green triangles, respectively) and with DCPIB (ClD, ClOD and ClOBD, blue
triangles point down, cyan diamonds, and magenta triangles point left,
respectively). Mean ± SE, n = 3–6 individual determinations. (A) For SOB vs.
SOBD, there was a statistically significant difference between groups as
determined by One-Way ANOVA [F(8, 21) = 51.65, p < 0.0005, n = 30], and
confirmed by paired t-test, *p ≤ 0.01 at 3 and 6 h and #p ≤ 0.005 at 9 h. (B)
For Cl, ClO, ClOB vs. ClD, ClOD, ClOBD, respectively, there was a statistically
significant difference between groups as determined by Kruskal–Wallis
One–Way ANOVA [F(8, 21) = 64.42, 77.64, and 45.44, p < 0.0005, n = 30],
and confirmed by paired t-test, *p < 0.05 at 3 h and #p < 0.005 at 6 and 9 h.
Data represent the mean ± SEM values. Representative results from 4 similar
experiments.
both Rb+ influx and K+ loss independently of the increasing
exposure to DCPIB, and that K+ loss was about twice the Rb+
influx across the different conditions. This difference may be
explained by the driving forces for Ki (∼140mM K
+
i /0mM
K+o ) and Rbo (0mM Rb
+
i /10mM Rb
+
o ). These findings indicate
that constitutive dephosphorylation of KCC3 could lead to cell
shrinking when VRAC is inhibited by DCPIB.
Effect of KCC3 Thr991/Thr1048
Dephosphorylation on Cell Volume Regulation in
Hypotonic Osmotic Stress
Given the potent Cl-dependent and Cl-independent Ki loss
induced by KCC3 AA, we speculated these cells might exhibit
different swelling properties compared to those expressing KCC3
WT. We therefore examined cell volume changes and RVD
in response to hypotonic challenge in KCC3 WT and KCC3
AA cells (see Materials and Methods for details). At baseline,
in isotonic conditions, both cell lines exhibited similar cell
volumes (Figure 11A). However, hypotonic conditions [HEPES-
MEM (150 mOsm/kg H2O)] elicited a ∼3.2 ± 0.5-fold increase
in cell volume (peak values) in KCC3 WT cells, compared
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FIGURE 7 | Constitutive KCC3 Thr991/Thr1048 dephosphorylation
elicits potent Rb+ influx through ouabain-sensitive (NKP) and
Cl-dependent (NKCC and KCC) pathways that are time-dependent and
partially sensitive to DCPIB. Rb+ influx was measured simultaneously with
the Ki contents of Figure 6 and as described in Materials and Methods,
during induction with doxycycline (1µg/ml) and ± DCPIB (50µM). (A–C)
Represent NKP, NKCC, and KCC without and with DCPIB (NKPD, NKCCD,
and KCCD), respectively. Black squares in the absence and red circles in the
presence of DCPIB. n = 3–6 individual determinations. There was a statistically
significant difference between groups as determined by One-Way ANOVA for
NKP vs. NKPD [F(8, 19) = 26.06], NKCC vs. NKCCD [F(8, 21) = 41.81] and
KCC vs. KCCD [F(8, 21) = 368.3], p < 0.0005, n = 30. Data represent the
mean ± SEM values. Representative results from 4 similar experiments.
to significantly less swelling in KCC3 AA cells [1.2 ± 0.3-
fold increase in cell volume (peak values)] (Figures 11A,B).
Two phases of cell volume changes were further analyzed in
Figures 11C,D. First, KCC3 WT cells showed a sharp swelling
increase upon hypotonic challenge (at a rate of 1.8 ± 0.3 % cell
volume/min); in contrast, KCC3AA cells exhibited a significantly
slower rate (1.05± 0.2 % cell volume/min). Secondly, KCC3WT
cells triggered RVD at a rate of 0.13 ± 0.01 % cell volume/min
(Figure 11D) and recovered to ∼50 ± 0.2 % of their original
volume in ∼20min; in contrast, KCC3 AA cells exhibited a
slower RVD rate (0.04± 0.007 % cell volume/min) (Figure 11D).
These data suggest that constitutive KCC3 Thr991/Thr1048
dephosphorylation renders cells less prone to acute swelling in
hypotonic osmotic stress.
Discussion
Hypotonic cell swelling triggers RVD to maintain cell volume,
resulting in K+ and Cl− (and obligated water) efflux via the
activation of K+ channels, VRACs, and KCC3 (Hoffmann
and Dunham, 1995). KCC3 Thr991/Thr1048 dephosphorylation
accompanies cell swelling (Rinehart et al., 2009; De Los
Heros et al., 2014), but the cellular physiology of this event
has not been systematically examined. We show constitutive
dephosphorylation of KCC3a Thr991/Thr1048, modeled via
alanine substitution at the involved residues (preventing
phosphorylation), is a potent mechanism of stimulating KCC3a
FIGURE 8 | Cl-dependent Rb+ influx and Ki content in constitutively
dephosphorylated KCC3 cells are DCPIB-sensitive. Lines indicate
doxycycline-induced Rb+ influx (A) and Ki content (B), which were assessed
in the following media: Cl− + 0.1mM ouabain (ClO), Cl− + (ouabain + 10µM
bumetanide) (ClOB), S + (ouabain + bumetanide) (SOB) after induction of
KCC3 T991A/T1048A (AA) (see Materials and Methods for details). (A)
Calculated Rb+ flux through NKCC, black squares and KCC, red circles as the
Cl-dependent, ouabain-insensitive, bumetanide-sensitive Rb+ influx, and
Cl-dependent, ouabain and bumetanide-insensitive Rb+ influx, respectively.
Calculation of NKCC in AA cells after induction may result in a negative or
positive value depending on the relative magnitude of the Rb+ influx in ClOB
with respect to ClO, i.e., CLO − CLOB = + or − NKCC (A); for Ki content (B)
ClO, black squares, CLOB, red circles and SOB, green triangles (see Results
and Discussion for further details). Flux time, 5min; n = 4 individual
determinations. *p < 0.05 and #p < 0.005 as determined by paired t-test with
respect to 0µM DCPIB; data represent the mean ± SEM values.
Representative results from 4 similar experiments.
activity, resulting in a rapid (<10min) and significant (>90%)
reduction in Ki via both Cl-dependent and Cl-independent
(and DCPIB-sensitive) pathways. These effects, along with the
associated inhibition of NKCC1 activity and increase in NKP
activity, render cells less prone to acute swelling in hypotonic
osmotic stress. Our studies with 85Rb+ and 39K+ under zero-
trans conditions used here and developed several decades ago
(Adragna et al., 1994; Adragna and Lauf, 1998), are in agreement
with previous studies utilizing radioactive 86Rb+ under steady
state (Rinehart et al., 2009; De Los Heros et al., 2014), and
corroborate and extend earlier work demonstrating the potency
of KCC3 Thr991/Thr1048 dephosphorylation for transporter
activation. Furthermore, and in contrast to previous studies,
our findings demonstrating an important role of the KCC3
Thr991/Thr1048 switch as a key regulator of Ki content and cell
volume in response to hypotonic stress are entirely novel.
In isotonic conditions, KCC3a is robustly phosphorylated at
Thr991/Thr1048 and functionally inactive. In these conditions,
and consistent with previous findings measuring unidirectional
transport with radioactive 86Rb+ under steady state (Rinehart
et al., 2009; De Los Heros et al., 2014), we found genetic
prevention of KCC3 phosphorylation at these sites elicited up
to a >25-fold increase in transporter activity relative to wild
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FIGURE 9 | Cl-independent Ki loss trigged by constitutive KCC3
Thr991/Thr1048 dephosphorylation is DCPIB-sensitive. Bars indicate
total doxycycline-induced Ki loss (T, red), Ki loss through Cl-dependent
cotransporters (NKCC + KCC, ClCOT, green), and K+ channel-sensitive Ki
loss (KCH, blue) when DCPIB, an inhibitor of volume regulated Cl− channels
(VRACs) and intermediate K+ channels, was applied in the induction (I),
preincubation (P), and/or flux (F) stages of the ion flux study. DCPIB inhibits
Cl-sensitive Ki loss. Representative results from a typical experiment done in
quadruplicates. Total number of similar experiments, N = 4. For T, there was a
statistically significant difference between groups as determined by One-Way
ANOVA [F(7, 24) = 5.15, p < 0.001, n = 32] or by Kruskal–Wallis One-Way
ANOVA [F(7, 24) = 4.46, p < 0.005, n = 32]. There was a statistically significant
difference between groups as determined by Kruskal–Wallis One-Way ANOVA
[F(8, 27) = 12.01, p < 0.0005, n = 36] for ClCOT but not for KCH
[F(7, 24) = 1.41, p > 0.2, n = 32. Data represent the mean ± SEM values.
However, there was a statistically significant difference for KCH, *p < 0.05
and #p < 0.005; and for TD (&p < 0.0005) by paired T-Test for the different
conditions shown in the figure and described in the text.
type KCC3. This constitutive KCC3 activity was associated with
an inhibition (and subsequent reversal) of NKCC1 activity.
The negative values of NKCC1 activity in tested conditions
(Figure 1A) likely represent Rb+ leak via NKCC1 in the absence
of bumetanide, since bumetanide in these conditions resulted
in an increase in intracellular Rb+ (ClO < ClOB). Constitutive
KCC3 activity was also associated with increase in the ouabain-
sensitive Rb+ uptake component, consistent with increased NKP
activity. Extracellular Na+ replacement with NMDG eliminated
NKP activity (Figure 3), suggesting constitutive KCC3 activity
increases cellular Na+ entry (which maximally activates NKP
in Na+ but not in Na-free medium). These data reveal a close
functional association between KCC3a and NKCC1/NKP in
the context of KCC3a activation, and suggest that attempts to
“specifically” inhibit or activate individual CCCs (e.g., blocking
NKCC1 or activating KCC2/3) will have effects on other
functionally related transport systems that aim to maintain a
steady state in ion content and cell volume.
KCC3 AA induction was also accompanied by a rapid and
significant Ki loss. About 50 % of this Ki loss was recovered in Cl-
free medium. Partial inhibition of Ki loss in sulfamate-containing
medium indicated that there are two components to this Ki loss:
a Cl-dependent and a Cl-independent Ki loss. The Cl-dependent
FIGURE 10 | Cl-dependent Rb+ influx and Ki loss triggered by
constitutive KCC3 Thr991/Thr1048 dephosphorylation is
DCPIB-sensitive. Bars indicate Rb+ influx through Cl-dependent
cotransporters (NKCC + KCC, cyan) and Ki loss (NKCC + KCC, magenta),
when DCPIB was applied in the induction (I), preincubation (P), and/or flux (F)
stages of the ion flux study. DCPIB inhibits Cl-dependent Rb+ influx and Ki
loss depending on the conditions. Representative results from 4 similar
experiments. For Rb+ (NKCC + KCC), there was a statistically significant
difference between groups as determined by One-Way ANOVA
[F(8, 27) = 48.75, p < 0.0005, n = 36]. For K
+ (NKK + KCC), there was a
statistically significant difference between groups as determined by
Kruskal–Wallis One-Way ANOVA [F(8, 27) = 20.51, p < 0.0005, n = 36]. Data
represent the mean ± SEM values.
Ki loss was inhibited by either replacement of extracellular Rb
+
with K+ or furosemide (2mM), suggesting a dependence on
KCC3 and NKCC1-mediated K+ efflux. While the Cl-dependent
component could thus be explained, the Cl-independent Ki loss
associated with KCC3 activation required further investigation.
We attempted to define this component by inhibiting it with
extracellular ion replacement studies or different inhibitors of
candidate transport pathways. TEA, clofilium, Ruthenium Red,
BAPTA, EDTA, RN-1734, and several other inhibitors had no
effect on the Cl-independent Ki loss under the conditions tested
(Supplementary Table 3). Because of the large Ki loss in such a
short period of time, a Ca-activated K+ channel, such as a BK
channel, was thought to be likely involved, as seen in human
red blood cells and in vascular smooth muscle, coronary arteries
and lens epithelial cells. Thus, 2mM TEA, which selectively
inhibits BK channels, was used, in contrast to 10mM, which
is the concentration used for most Ca-sensitive K+ channels of
intermediate or smaller conductance. To test the basic idea that
Ca+ was involved, different approaches, i.e., with inhibitors and
chelators, were used, with negative results. Next, clofilium was
used as a Ca-independent K+ channel blocker, but also with no
effect. However, it is possible that BAPTA AM/EDTA under the
conditions used in this study may not have effectively depleted
other internal sources of Cai.
However, DCPIB, an inhibitor of VRACs (and also
intermediate K+ conductance channels), completely suppressed
the Cl-independent Ki loss when used during induction +
flux conditions. These results show that constitutive KCC3
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FIGURE 11 | Constitutive KCC3 Thr991/Thr1048 dephosphorylation
reduces acute cell swelling in response to hypotonic osmotic stress.
(A) Representative relative change in cell volume after hypotonic swelling in
KCC3 WT and KCC3 AA cells (see Materials and Methods for details). Cells
were exposed to isotonic HEPES-MEM (310 mOsm/kg H2O), followed by
hypotonic HEPES-MEM (150 mOsm/kg H2O) for 20min, and subsequently
isotonic HEPES-MEM for 5min. For drug treatment, cells were pre-incubated
with 2mM furosemide for 15min prior to the osmotic stress. Furosemide was
present throughout the experiment. (B) Summary data of cell volume
increase. Inset shows representative traces of relative change in cell water in
KCC3 AA cells in presence or absence of furosemide. Data are means ± SE.
n = 5, *P < 0.05 vs. WT control. P = 0.1 WT + furosemide vs. AA +
furosemide. (C) Rate of cell volume change. Bar graphs represent the rate
constants from the slopes (red line) calculated by fitting a linear regression to
the cell water volume data (relative change) during the initial swelling
response (5–6min, inset: slopes in red). *p < 0.05 vs. WT. (D) Regulatory
volume decrease (RVD). Bar graphs represent the rate constants from the
slopes (red line) calculated by fitting a linear regression to the cell volume
relative change data during 10–24min of cell volume recovery (inset: slopes
in red). Data are means ± SE. n = 5 experiments. *p < 0.05 vs. WT.
activation elicits a rapid and pronounced decrease in Ki via Cl-
dependent/CCC-mediated pathways, as well as Cl-independent
pathways possibly dependent on VRAC activity, such as IClswell
(Voss et al., 2014), or possibly via a yet-unidentified K+
conductance that is not inhibited by either TEA or clofilium. In
any event, the results obtained with DCPIB seem to shed light
on the mechanism by which K+ is lost independently of Cl−
when the KCC3 AAmutant is overexpressed. Identifying this K+
transport pathway will be an interesting topic of detailed future
investigation.
The mechanisms by which over-expression of KCC3 AA,
resulting in constitutively active K+-Cl− cotransport, leads
to the associated changes in NKCC and NKP, and Ki and
cell volume, are summarized in the model in Supplementary
Figures 3, 4. Supplementary Figure 3 shows the potential
mechanisms accounting for our experimental findings during
KCC3 AA induction with doxycycline and preincubation.
These experiments were performed in the presence of 5mM
extracellular K+ (Ko). During these time intervals, KCC3 AA
induction (step 1) would trigger KCC-mediated outwardly-
directed K+ and Cl− loss, and consequently, cell shrinkage. This
would initially stimulate NKCC1 (step 3), increasing intracellular
Na+ and Cl− (step 4). The increase in intracellular Na+ would
stimulate NKP, bringing more K+ into cells. The increase in
intracellular K+ and Cl− (and associated influx of osmotically-
obliged water) would then lead to a “rebound” transient cell
swelling and membrane depolarization (step 5), activating
DCPIB-sensitive VRACs (i.e., Lrrc8-dependent ICl−swell) (step 6),
and indirectly, inducing Ki loss (step 7).During the flux procedure
(Supplementary Figure 4), which measures Rb+ influx through
KCC, NKCC and NKP in the presence of 10mM Rb, and Ki
content at 0 Ko, the nominally infinite outward gradient for K
+
causes an outward efflux of K+ and Cl− through KCC (step 1),
and enhanced entry of Rb+ through KCC, NKCC and NKP (step
2). Rb+ will enter up to a certain level after which back-flux
ensues (Sachs, 1967), exiting through NKCC1 (i.e., in a reversal of
activity) and blocking its further entry through inwardly directed
NKCC1 (step 3). Treatment with DCPIB during induction alone,
or induction and pre-incubation, and afterwards during flux,
would likely directly inhibit ICl−swell and indirectly inhibit Cl-
sensitive K+ loss, as well as the aforementioned pathways for Rb+
and K+ transport (KCC and NKP), whereas its effect on NKCC1
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would appear to be inhibitory or stimulatory depending on the
conditions (Figures 6–8).
We examined cell volume changes and RVD in response to
acute hypotonic challenge in KCC3 WT and KCC3 AA cells.
In these experiments, KCC3 AA cells exhibited significantly less
acute cell swelling than KCC3 WT cells in hypotonic conditions.
However, KCC3 WT cells exhibited a mildly brisker RVD rate
than KCC3 AA cells. These data suggest that constitutive KCC3
activity, achieved via tonic Thr991/Thr1048 dephosphorylation,
might render cells less prone to cell swelling in response to
hypotonic osmotic stress—particularly during the early phases of
physiological perturbation. It remains to be determined whether
the reduced acute cell swelling in KCC3 AA cells in these
conditions is due solely from increased KCC3-mediated ionic
efflux, or from the combined effects of this and other volume-
regulated transport proteins.
Multiple diseases exhibit dysregulation of cell volume due
to aberrant transmembrane ionic transport (Epstein et al.,
1995). For example, sickle cell vaso-occlusive events caused by
sickle cell dehydration have been associated with hyperactive
KCC-mediated cellular K+ and Cl− efflux, suggesting KCC
inhibition might be a pharmacotherapeutic strategy to prevent
sickle cell dehydration and HbS polymerization (Brugnara,
2001). This could be achieved by promoting the inhibitory
phosphorylation of KCC3 at Thr991/Thr1048 via PP1/PP2a
phosphatase inhibition. Conversely, ischemic and traumatic
cerebral edema is associated with glial cell swelling due in part to
NKCC1-dependent Na+, K+, and Cl− intracellular accumulation
(Su et al., 2002; Lenart et al., 2004; Gagnon et al., 2007). In
this context, stimulating KCC3 by antagonizing Thr991/Thr1048
phosphorylation would be expected to not only facilitate K+
and Cl− efflux and cell shrinkage, but also secondarily decrease
the pathological elevation in NKCC1 activity (see Figures 2, 4).
The necessity for KCC3-mediated cell volume regulation in the
human nervous system has been demonstrated by the autosomal
recessive human disease Andermann syndrome, caused by loss-
of-function mutations in KCC3, which results in axonal swelling,
periaxonal fluid accumulation, and neurodegeneration due to
defective RVD (Boettger et al., 2003; Byun and Delpire, 2007).
In elucidating the normal physiological functions of the
key phospho-regulatory sites of KCC3, our study suggests
that antagonizing the inhibitory phosphorylation of KCC3 at
Thr991/Thr1048 would activate KCC3, decrease cellular K+
content, and resist acute cell swelling. This could be achieved by
inhibiting the WNK-SPAK protein kinase complex (Alessi et al.,
2014). SPAK phosphorylates Thr1048 directly, but not Thr991
(Rinehart et al., 2009; De Los Heros et al., 2014), and WNK1
is necessary for both Thr991 and Thr1048 phosphorylation (De
Los Heros et al., 2014). Inhibiting the WNK-SPAK pathway
would have the added benefit of concurrently decreasing the
stimulatory phosphorylation of NKCC1 at Thr212/Thr217,
sites required for NKCC1 activity (Thastrup et al., 2012)
and pathologically up-regulated in ischemic edema (O’Donnell,
2014). This powerful coincident reduction in NKCC1-mediated
ion influx and stimulation of KCC3-mediated ion efflux would
seem ideally suited to counter acute pathological cell swelling,
particularly in glia, in hypotonic swelling conditions as seen
in acute hyponatremia from water intoxication. Activation of
this KCC3 switch might also be of use in isosmotic swelling,
which results from activity-dependent transporter and channel-
mediated increases in cellular ionic load (Kahle et al., 2009;
Kaila et al., 2014), as in ischemic stroke. Critical to these
considerations will be a determination of how constitutive KCC3
Thr991/Thr1048 dephosphorylation might affect long-term cell
viability, and CNS and PNS structure and function, in the CNS
in vivo. We are currently evaluating this in knock-in KCC3
mice carrying double-alanine mutation at Thr991/Thr1048.
Lastly, dephosphorylation of the homologous residues in KCC2
(Thr906/Thr1107) might also be a novel method of stimulating
KCC2 in diseased neurons to promote Cl− extrusion and restore
GABAergic inhibition (Kahle et al., 2013).
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